Skip to main content
Signal8

ELI LILLY & Co (LLY)

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer. For autoimmune and inflammatory conditions, the company markets Olumiant for rheumatoid arthritis, and Taltz, which addresses plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Addressing neurological and pain management needs, Eli Lilly provides Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is available for migraine prevention and episodic cluster headaches, while Zyprexa treats schizophrenia, bipolar I disorder, and aids in bipolar maintenance. Other significant products include Bamlanivimab and etesevimab, along with Bebtelovimab, both developed for COVID-19. Cialis is offered for erectile dysfunction and benign prostatic hyperplasia, and Forteo is available for osteoporosis. Eli Lilly actively engages in strategic collaborations with numerous partners, including Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Established in 1876, Eli Lilly and Company maintains its corporate headquarters in Indianapolis, Indiana.

Sector: Pharmaceutical Preparations

Industry: Drug Manufacturers - General

Eli Lilly and Company logo

Eli Lilly and Company

NYSE:LLYHealthcare
-2.54%$1273.46
AH Close$1279.00+0.44%vs close
Mkt Cap$1.2T
Float849.67M
O/S941.36M
Inst Own71.8%
SI0.8%
Div Yield0.53%
Dilution
Eli Lilly and Company logoNYSE:LLY$1273.46-2.54%
Delisting Issues Timeline
Financials Summary
Revenue$65.18B
Net Income$20.64B
Total Assets$112.48B
Free Cash Flow$8.97B
Debt & Equity
Debt 62%
Equity 38%
Total Debt$42.5B
Total Equity$26.54B
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in LLY's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$112.48B
Liabilities$85.94B
Accounts Receivable$20.16B
Accounts Payable$5.38B
Inventory$13.74B
PP&E (Net)$24.68B
Goodwill$5.9B
Intangible Assets$6.52B
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997FY 1996FY 1995FY 1994FY 1993FY 1992FY 1991FY 1990FY 1989FY 1988FY 1987FY 1986
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-311991-12-311990-12-311989-12-311988-12-311987-12-311986-12-31
Revenue$65.18B$45.04B$34.12B$28.54B$28.32B$24.54B$22.32B$21.49B$19.97B$21.22B$19.96B$19.62B$23.11B$22.6B$24.29B$23.08B$21.84B$20.37B$18.63B$15.69B$14.65B$13.86B$12.58B$11.08B$11.54B$10.86B$10B$9.24B$7.99B$7B$6.76B$5.71B$6.45B$6.17B$5.73B$5.19B$4.18B$4.07B$3.64B$3.72B
YoY Growth44.7%32.0%19.6%0.8%15.4%9.9%3.8%7.6%-5.9%6.3%1.7%-15.1%2.3%-6.9%5.2%5.7%7.2%9.3%18.8%7.1%5.7%10.1%13.6%-4.0%6.3%8.6%8.3%15.6%14.1%3.5%18.4%-11.5%4.6%7.7%10.3%24.3%2.6%11.7%-2.1%-
Cost of Revenue$11.05B$8.42B$7.08B$6.63B$7.31B$5.48B$4.72B$4.68B$4.45B$5.71B$5.04B$4.93B$4.91B$4.8B$5.07B$4.37B$4.25B$4.38B$4.25B$3.55B$3.47B$3.22B$2.68B$2.18B$2.16B$1.62B$1.66B$1.52B$1.44B$1.33B$1.33B$1.25B$1.56B$1.53B$1.35B$1.28B$1.03B$1.13B$1.12B$1.17B
Gross Profit$54.13B$36.63B$27.04B$21.91B$21.01B$19.06B$17.6B$16.81B$15.53B$15.51B$14.92B$14.68B$18.2B$17.81B$19.22B$18.71B$17.59B$16B$14.38B$12.14B$11.17B$10.63B$9.91B$8.9B$9.38B$9.24B$8.34B$7.71B$6.55B$5.67B$5.43B$4.46B$4.89B$4.64B$4.37B$3.92B$3.15B$2.94B$2.53B$2.55B
Gross Margin83.0%81.3%79.2%76.8%74.2%77.7%78.8%78.2%77.7%73.1%74.8%74.9%78.8%78.8%79.1%81.1%80.6%78.5%77.2%77.4%76.3%76.7%78.7%80.4%81.3%85.1%83.4%83.5%82.0%81.0%80.3%78.2%75.8%75.2%76.3%75.4%75.4%72.2%69.3%68.6%
Research and Development$13.34B$10.99B$9.31B$7.19B$6.93B$5.98B$5.59B$5.05B$5.1B$5.31B$4.8B$4.73B$5.53B$5.28B$5.02B$4.88B$4.33B$3.84B$3.49B$3.13B$3.03B$2.69B$2.35B$2.15B$2.24B$2.02B$1.78B$1.74B$1.37B$1.19B$1.04B$838.7M$0$0$0$0$0$0$0$0
Selling, General, and Administrative$11.09B$8.59B$6.94B$6.07B$6.14B$5.87B$6B$5.73B$6.18B$6.33B$6.53B$6.62B$7.13B$7.51B$7.88B$7.05B$6.89B$6.63B$6.1B$4.89B$4.5B$4.28B$4.06B$3.42B$3.42B$3.23B$2.76B$2.66B$2.23B$1.89B$1.85B$1.4B$3.84B$3.11B$2.3B$2.13B$1.75B$1.69B$1.75B$1.51B
Other$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$435.8M$439.7M$490.4M$509.8M$543.5M$553.7M$432.2M$398.3M$368.1M$299.5M$247.5M$229.3M$204M$184.3M$177.7M
Total Operating Expenses$24.43B$19.59B$16.25B$13.26B$13.07B$11.85B$11.6B$10.79B$11.28B$11.64B$11.33B$11.35B$12.66B$12.79B$12.9B$11.94B$11.22B$10.47B$9.58B$8.02B$7.52B$6.98B$6.41B$5.57B$5.65B$5.68B$4.98B$4.89B$4.11B$3.63B$3.45B$2.67B$4.24B$3.48B$2.6B$2.38B$1.98B$1.89B$1.93B$1.69B
Operating Income (EBIT)$29.7B$17.04B$10.79B$8.65B$7.93B$7.21B$6B$6.03B$4.25B$3.87B$3.59B$3.33B$5.55B$5.02B$6.32B$6.77B$6.37B$5.53B$4.8B$4.13B$3.65B$3.66B$3.5B$3.33B$3.73B$3.56B$3.36B$2.82B$2.44B$2.04B$1.98B$1.79B$652.6M$1.16B$1.77B$1.54B$1.16B$1.05B$595M$860.3M
Operating Margin45.6%37.8%31.6%30.3%28.0%29.4%26.9%28.0%21.3%18.2%18.0%17.0%24.0%22.2%26.0%29.3%29.2%27.1%25.8%26.3%24.9%26.4%27.8%30.0%32.3%32.8%33.6%30.6%30.5%29.2%29.3%31.4%10.1%18.7%30.9%29.7%27.9%25.7%16.3%23.1%
Interest Expense$795.3M$780.6M$485.9M$331.6M$339.8M$359.6M$400.6M$242.5M$225M$185.2M$161.2M$148.8M$160.1M$177.8M$186M$185.5M$261.3M$228.3M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Interest Income$153.3M$175.2M$173.6M$62.8M$25.4M$33M$80.4M$159.3M$166.4M$108.7M$87M$121M$119.7M$105M$79.9M$51.9M$75.2M$210.7M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)-$3.96B-$4.36B-$4.23B-$1.85B-$1.78B$19.1M-$733.5M-$2.35B-$1.95B-$497.3M-$802.1M-$328.4M$341.2M$392.9M-$968.4M-$247M-$1.01B-$6.84B-$926.1M-$707.4M-$931.1M-$716.8M-$240.1M$130M-$177.7M$299M-$118.3M-$159.5M$462.7M$87M-$216.2M-$96.3M$49.3M$26.8M$110.9M$59.6M$165.1M$69M$0$16M
Income Before Tax (EBT)$25.73B$12.68B$6.55B$6.81B$6.16B$7.23B$5.27B$3.68B$2.3B$3.37B$2.79B$3B$5.89B$5.41B$5.35B$6.53B$5.36B-$1.31B$3.88B$3.42B$2.72B$2.94B$3.26B$3.46B$3.55B$3.86B$3.25B$2.67B$2.9B$2.13B$1.77B$1.7B$701.9M$1.18B$1.88B$1.6B$1.33B$1.12B$595M$876.3M
Income Tax Expense$5.09B$2.09B$1.31B$561.6M$573.8M$1.04B$628M$529.5M$2.39B$636.4M$381.6M$609.8M$1.2B$1.32B$1B$1.46B$1.03B$764.3M$923.8M$755.3M$715.9M$1.13B$700.9M$749.8M$742.7M$800.9M$698.7M$568.7M$885.2M$505.6M$459M$513.5M$210.8M$354.7M$564.5M$471.7M$390.4M$354.8M$184.5M$318.1M
Net Income$20.64B$10.59B$5.24B$6.24B$5.58B$6.19B$8.32B$3.23B-$204.1M$2.74B$2.41B$2.39B$4.68B$4.09B$4.35B$5.07B$4.33B-$2.07B$2.95B$2.66B$1.98B$1.81B$2.56B$2.71B$2.78B$3.06B$2.72B$2.1B-$385.1M$1.52B$2.29B$1.29B$480.2M$708.7M$1.31B$1.13B$939.5M$761M$643.7M$558.2M
Net Income Margin31.7%23.5%15.4%21.9%19.7%25.2%37.3%15.0%-1.0%12.9%12.1%12.2%20.3%18.1%17.9%22.0%19.8%-10.2%15.8%17.0%13.5%13.1%20.4%24.4%24.1%28.2%27.2%22.7%-4.8%21.8%33.9%22.5%7.4%11.5%23.0%21.7%22.5%18.7%17.7%15.0%
Supplementary Data
EPS23.0711.765.836.575.856.478.693.14-0.192.492.182.154.193.573.904.583.94-1.892.712.451.821.672.382.512.582.832.501.91-0.351.392.021.110.400.611.130.980.800.670.560.51
Diluted EPS22.9511.715.806.575.856.478.693.13-0.192.492.182.154.193.573.904.583.94-1.892.712.451.811.662.372.502.552.792.461.87-0.341.362.021.110.400.611.130.980.800.670.560.51
Weighted Average OS898.00M900.61M899.38M950.18M953.65M956.59M957.53M1.03B1.05B1.10B1.11B1.11B1.12B1.15B1.11B1.11B1.10B1.09B1.09B1.09B1.09B1.08B1.08B1.08B1.08B1.08B1.09B1.10B1.10B1.09B1.14B1.16B1.20B1.16B1.16B1.15B1.17B1.14B1.15B1.09B
EBITDA$31.69B$18.81B$8.57B$8.66B$8.04B$8.91B$6.9B$5.53B$4.1B$5.06B$4.38B$4.53B$7.5B$7.05B$6.91B$8.04B$6.92B$43.3M$5.85B$4.93B$4.38B$4.26B$4.05B$3.82B$4.18B$4B$3.8B$3.31B$2.95B$2.59B$2.54B$2.23B$1.05B$1.52B$2.07B$1.79B$1.39B$1.25B$779.3M$1.04B
EBITDA Margin48.6%41.8%25.1%30.3%28.4%36.3%30.9%25.7%20.5%23.8%21.9%23.1%32.4%31.2%28.4%34.8%31.7%0.2%31.4%31.4%29.9%30.7%32.2%34.5%36.3%36.8%38.0%35.9%36.9%37.0%37.5%39.0%16.3%24.7%36.1%34.4%33.4%30.7%21.4%27.9%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997FY 1996FY 1995FY 1994FY 1993FY 1992FY 1991FY 1990FY 1989FY 1988FY 1987FY 1986
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-311991-12-311990-12-311989-12-311988-12-311987-12-311986-12-31
Assets
Current Assets
Cash and Cash Equivalents$7.16B$3.27B$2.82B$2.07B$3.82B$3.66B$2.34B$7.32B$6.54B$4.58B$3.67B$3.87B$3.83B$4.02B$5.92B$5.99B$4.46B$5.5B$3.22B$3.11B$3.01B$5.37B$2.76B$1.95B$2.7B$4.11B$3.7B$1.5B$1.95B$813.7M$999.5M$536.9M$539.6M$432.4M$479.2M$350.2M$323M$761.5M$1.03B$486M
Short-Term Investments$105M$154.8M$109.1M$144.8M$90.1M$24.2M$101M$88.2M$1.5B$1.46B$785.4M$955.4M$1.57B$1.67B$974.6M$733.8M$34.7M$429.4M$1.61B$781.7M$2.03B$2.1B$957M$1.71B$1.03B$503.3M$135.6M$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$7.27B$3.42B$2.93B$2.21B$3.91B$3.68B$2.44B$7.41B$8.03B$6.04B$4.45B$4.83B$5.4B$5.68B$6.9B$6.73B$4.5B$5.93B$4.83B$3.89B$5.04B$7.46B$3.71B$3.65B$3.73B$4.62B$3.84B$1.5B$1.95B$813.7M$999.5M$536.9M$539.6M$432.4M$479.2M$350.2M$323M$761.5M$1.03B$486M
Accounts Receivable$20.16B$13.28B$11.34B$8.56B$8.13B$6.93B$5.54B$5.78B$5.26B$4.77B$4.07B$3.8B$4.02B$3.89B$4.24B$4.16B$3.83B$3.28B$3.7B$2.69B$2.76B$2.55B$2.34B$2.07B$1.7B$1.97B$1.84B$2.24B$1.88B$1.74B$1.81B$1.83B$950.1M$1.05B$1.13B$878.7M$845.8M$761.7M$931.5M$779.1M
Inventory$13.74B$7.59B$5.77B$4.31B$3.89B$3.98B$3.19B$3.1B$4.46B$3.56B$3.45B$2.74B$2.93B$2.64B$2.3B$2.52B$2.85B$2.49B$2.52B$2.27B$1.88B$2.29B$1.96B$1.5B$1.06B$883.1M$899.6M$999.9M$900.7M$881.4M$839.6M$968.9M$1.1B$938.4M$796.9M$673M$599.5M$674.3M$615.5M$694.6M
Other Current Assets$147M$111.4M$149.5M$7.3M$0$0$0$2.23B$0$0$0$0$0$0$654.9M$608.9M$271M$382.1M$642.8M$519.2M$756.4M$255.3M$490.4M$331.7M$223.3M$475.6M$477.1M$667.5M$589.3M$459.1M$491.1M$621.9M$1.1B$584.1M$537.2M$599.4M$506.1M$217.2M$146.2M$112.5M
Total Current Assets$55.63B$32.74B$25.73B$18.03B$18.45B$17.46B$13.71B$20.55B$19.2B$15.1B$12.57B$11.93B$13.1B$13.04B$14.25B$14.84B$12.49B$12.45B$12.32B$9.69B$10.8B$12.84B$8.76B$7.8B$6.94B$7.94B$7.06B$5.41B$5.32B$3.89B$4.14B$3.96B$3.7B$3.01B$2.94B$2.5B$2.27B$2.41B$2.72B$2.07B
Long-Term Assets
Property, Plant & Equipment Net$24.68B$17.1B$12.91B$10.14B$8.99B$8.68B$8.4B$8B$8.83B$8.25B$8.05B$7.96B$7.98B$7.76B$7.76B$7.94B$8.2B$8.63B$8.58B$8.15B$7.91B$7.55B$6.54B$5.29B$4.53B$4.18B$3.98B$4.1B$4.1B$4.31B$4.24B$4.41B$4.2B$4.07B$3.78B$2.94B$2.11B$1.81B$1.64B$1.53B
Goodwill$5.9B$5.77B$4.94B$4.07B$3.89B$3.77B$3.68B$1.37B$4.37B$3.97B$4.04B$1.76B$1.52B$1.5B$1.43B$1.42B$1.18B$1.17B$745.7M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$6.52B$6.17B$6.91B$7.21B$7.69B$7.45B$6.62B$1.07B$4.03B$4.36B$5.03B$2.88B$2.81B$3.25B$3.69B$3.39B$2.52B$2.89B$1.71B$0$0$0$0$0$0$0$118.6M$1.52B$1.55B$4.03B$4.11B$4.41B$1.24B$1.35B$1.3B$1.22B$453.6M$409.9M$395.7M$478.8M
Long-Term Investments$2.8B$3.22B$3.05B$2.9B$3.21B$2.97B$1.96B$2.02B$5.68B$5.21B$3.65B$4.57B$7.62B$6.31B$4.03B$1.78B$1.16B$1.54B$577.1M$1B$1.3B$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$9.96B$8B$5.48B$2.79B$2.49B$2.83B$2.57B$2.61B$0$0$0$1.47B$792.8M$1.05B$0$0$0$382.1M$583.6M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$6.99B$5.72B$4.99B$4.34B$4.08B$3.48B$2.34B$8.3B$2.87B$1.91B$2.22B$5.74B$1.42B$1.49B$2.49B$1.62B$1.92B$2.15B$2.37B$3.11B$4.58B$4.48B$6.38B$5.94B$4.96B$2.57B$1.67B$1.57B$1.6B$2.08B$1.93B$1.72B$487.7M$242.5M$276.2M$480.7M$1.01B$631.5M$492.6M$517.2M
Total Long-Term Assets$56.85B$45.98B$38.28B$31.46B$30.35B$29.17B$25.58B$23.36B$25.78B$23.7B$23B$24.38B$22.14B$21.36B$19.41B$16.16B$14.97B$16.76B$14.56B$12.26B$13.79B$12.03B$12.92B$11.24B$9.5B$6.75B$5.77B$7.19B$7.26B$10.42B$10.27B$10.55B$5.93B$5.67B$5.36B$4.64B$3.57B$2.85B$2.53B$2.52B
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0-$87M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$112.48B$78.71B$64.01B$49.49B$48.81B$46.63B$39.29B$43.91B$44.98B$38.81B$35.57B$36.31B$35.25B$34.4B$33.66B$31B$27.46B$29.21B$26.79B$21.96B$24.58B$24.87B$21.68B$19.04B$16.43B$14.69B$12.83B$12.6B$12.58B$14.31B$14.41B$14.51B$9.62B$8.67B$8.3B$7.14B$5.85B$5.26B$5.25B$4.6B
Liabilities
Current Liabilities
Accounts Payable$5.38B$3.23B$2.6B$1.93B$1.67B$1.61B$1.41B$1.21B$1.41B$1.35B$1.34B$1.13B$1.12B$1.19B$1.13B$1.07B$968.1M$885.8M$924.4M$789.4M$781.3M$648.6M$875.9M$676.9M$624.1M$661.9M$445.5M$1.19B$985.5M$829.3M$1.02B$878.2M$329.6M$323.6M$276.3M$259.9M$196.2M$0$0$0
Short-Term Debt$1.64B$5.12B$6.9B$1.5B$1.54B$8.7M$1.5B$1.1B$3.71B$1.94B$6.1M$2.69B$1.01B$11.9M$1.52B$156M$27.4M$5.85B$413.7M$219.4M$734.7M$2.02B$196.5M$545.4M$286.3M$184.3M$241.5M$181.4M$227.6M$1.21B$1.91B$2.72B$524.8M$591.2M$690.2M$1.24B$134M$127M$238.2M$230.9M
Current Income Tax Payable$5.88B$0$3.85B$475.1M$126.9M$495.1M$160.6M$393.4M$532.9M$119.1M$358.9M$93.5M$254.4M$143.5M$261.6M$457.5M$346.7M$229.2M$238.4M$640.6M$884.9M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$28.21B$7.15B$4.93B$3.91B$10.68B$9.3B$3.1B$3.69B$7.82B$6.61B$3.43B$3.76B$4.72B$4.99B$5.15B$4.56B$4.33B$5.32B$3.06B$3.42B$3.65B$4.45B$4.48B$3.84B$4.29B$4.11B$3.25B$3.24B$2.98B$2.18B$2.04B$2.07B$2.07B$1.48B$1.31B$1.32B$998.6M$1.16B$1.21B$931.6M
Total Current Liabilities$35.23B$28.38B$27.29B$17.14B$15.05B$12.48B$11.78B$11.89B$14.54B$10.99B$8.23B$11.21B$8.92B$8.39B$8.93B$7.1B$6.57B$13.11B$5.27B$5.09B$5.72B$7.59B$5.55B$5.06B$5.2B$4.96B$3.94B$4.61B$4.19B$4.22B$4.97B$5.67B$2.93B$2.4B$2.27B$2.82B$1.33B$1.29B$1.45B$1.16B
Long-Term Liabilities
Long-Term Debt$40.87B$28.53B$18.32B$14.74B$15.35B$16.59B$13.82B$9.2B$9.93B$8.37B$7.97B$5.35B$4.2B$5.52B$5.46B$6.77B$6.63B$4.62B$4.59B$3.49B$5.76B$4.49B$4.69B$4.36B$3.13B$2.63B$2.81B$2.19B$2.33B$2.52B$2.59B$2.13B$835.2M$582.3M$395.5M$277M$269.5M$387.7M$365.7M$395.3M
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$87.3M$1.73B$2.1B$2.19B$1.31B$0$0$0$0$0$0$0$0$84.8M$74.7M$287.5M$62.2M$695.1M$620.4M$0$0$0$91.6M$137M$247.9M$215.5M$376M$295.5M$188.9M$127.5M$169.7M$415.6M$351.2M$300.4M$235.2M$297.5M$298.4M
Other Long-Term Liabilities$9.85B$7.54B$7.53B$6.75B$7.52B$9.64B$8.32B$10.6B$8.85B$5.37B$4.78B$5.85B$4.49B$5.72B$5.73B$4.72B$4.65B$4.68B$3.05B$2.33B$1.61B$1.24B$1.67B$1.35B$995M$957.9M$927.9M$1.13B$1.04B$1.09B$1.12B$1.17B$1.16B$630.1M$249.4M$229.5M$192.2M$125.7M$100.9M$0
Total Long-Term Liabilities$50.71B$36.07B$25.85B$21.58B$24.6B$28.33B$24.81B$21.11B$18.78B$13.74B$12.75B$11.18B$8.69B$11.24B$11.19B$11.49B$11.37B$9.37B$7.93B$5.89B$8.07B$6.35B$6.36B$5.7B$4.13B$3.68B$3.88B$3.56B$3.58B$3.98B$4.01B$3.48B$2.13B$1.38B$1.06B$857.7M$762.1M$748.6M$764.1M$693.7M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0-$595.9M$0$0$0$0$0$0$168.5M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$85.94B$64.44B$53.14B$38.71B$39.65B$40.81B$36.59B$33B$33.31B$24.73B$20.98B$20.92B$17.61B$19.63B$20.12B$18.59B$17.94B$22.48B$13.37B$10.97B$13.79B$13.95B$11.91B$10.77B$9.33B$8.64B$7.81B$8.17B$7.77B$8.21B$8.98B$9.15B$5.05B$3.78B$3.33B$3.68B$2.09B$2.04B$2.21B$1.86B
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$3.01B$3.01B$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$590M$592.4M$593.6M$594.1M$596.3M$598.2M$598.8M$661M$687.9M$688.5M$691.3M$694.6M$698.5M$716.6M$724.1M$721.3M$0$0$709.5M$0$706.9M$708M$702.3M$702.1M$702.7M$704.4M$682M$0$0$0$0$0$0$0$0$0$0$0$0$0
Retained Earnings$24.47B$13.54B$10.31B$10.04B$8.96B$7.83B$4.92B$11.4B$13.89B$16.05B$16.01B$16.48B$16.99B$16.09B$14.9B$12.73B$9.83B$7.65B$11.81B$10.93B$10.03B$9.72B$9.47B$8.5B$7.41B$6.22B$4.99B$4.23B$4.48B$7.21B$6.48B$5.06B$4.5B$4.74B$4.69B$4.55B$4.07B$3.83B$3.4B$3.04B
Comprehensive Income & Other-$2.88B-$4.32B-$4.33B-$3.84B-$4.34B-$9.51B-$6.52B-$8.74B-$8.73B-$8.29B-$4.58B-$3.99B-$2B-$3.8B-$3.86B-$2.67B-$2.47B-$5.51B-$2.72B-$4.12B-$3.16B-$2.53B-$2.91B-$3.43B-$3.51B-$3.38B-$546.3M$0$0-$2.79B-$2.59B$0$0$0$0$0$0$0$0$0
Other Stockholders' Equity$1.48B$54.7M-$134M$13.1M-$575.6M-$2.79B-$2.91B-$2.23B-$2.99B-$2.73B-$2.13B-$1.8B-$59.5M-$2.04B-$2.08B-$1.03B-$306.7M-$919.6M$987.7M$54M$57.8M$487.3M-$407.9M-$928.6M-$1.01B-$880.7M-$654.6M$200.8M$162.5M-$1.11B-$1.05B$293.5M$67.9M$149M$273.1M-$1.08B-$308.3M-$602.1M-$352.9M-$301.6M
Total Equity$26.54B$14.19B$10.77B$10.65B$8.98B$5.64B$2.61B$9.83B$11.59B$14.01B$14.57B$15.37B$17.63B$14.77B$13.54B$12.42B$9.52B$6.74B$13.5B$10.98B$10.79B$10.92B$9.76B$8.27B$7.1B$6.05B$5.01B$4.43B$4.65B$6.1B$5.43B$5.36B$4.57B$4.89B$4.97B$3.47B$3.76B$3.23B$3.04B$2.74B
Minority Interest$0$79.5M$91.8M$125.6M$175.6M$183.6M$92.2M$1.08B$75.7M$72.8M$19M$14.9M$9.3M$8.7M-$6.1M-$7.5M$1.6M$0$0$0$0$0$0$0$0$0$0$0$160M$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$112.48B$78.64B$63.91B$49.36B$48.63B$46.45B$39.19B$42.83B$44.91B$38.73B$35.55B$36.29B$35.24B$34.39B$33.67B$31.01B$27.46B$29.21B$26.87B$21.96B$24.58B$24.87B$21.68B$19.04B$16.43B$14.69B$12.83B$12.6B$12.42B$14.31B$14.41B$14.51B$9.62B$8.67B$8.3B$7.14B$5.85B$5.26B$5.25B$4.6B
Supplementary Data
Total Debt$42.5B$33.64B$25.23B$16.24B$16.88B$16.6B$15.8B$10.3B$13.65B$10.31B$7.98B$8.06B$5.21B$5.53B$6.99B$6.93B$6.66B$10.46B$5.01B$3.71B$6.5B$6.51B$4.88B$4.9B$3.42B$2.82B$3.05B$2.37B$2.55B$3.73B$4.5B$4.85B$1.36B$1.17B$1.09B$1.52B$403.5M$514.7M$603.9M$626.2M
Net Debt$35.34B$30.38B$22.41B$14.17B$13.07B$12.94B$13.47B$2.98B$7.11B$5.72B$4.31B$4.18B$1.38B$1.51B$1.06B$933.3M$2.2B$4.97B$1.79B$604.5M$3.49B$1.15B$2.13B$2.96B$716.1M-$1.3B-$647M$871.2M$606.2M$2.92B$3.5B$4.31B$820.4M$741.1M$606.5M$1.17B$80.5M-$246.8M-$427M$140.2M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997FY 1996FY 1995FY 1994FY 1993FY 1992FY 1991FY 1990FY 1989
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-311991-12-311990-12-311989-12-31
Operating Activities
Net Income$20.64B$10.59B$5.24B$6.24B$5.58B$6.19B$8.32B$3.23B-$204.1M$2.74B$2.41B$2.39B$4.68B$4.09B$4.35B$5.07B$4.33B-$2.07B$2.95B$2.66B$1.98B$1.81B$2.56B$2.71B$2.78B$3.06B$2.72B$2.11B-$385.1M$1.52B$2.29B$1.29B$491.1M$827.6M$1.31B$1.13B$939.5M
Depreciation & Amortization$2B$1.77B$1.53B$1.52B$1.55B$1.32B$1.23B$1.61B$1.57B$1.5B$1.43B$1.38B$1.45B$1.46B$1.37B$1.33B$1.3B$1.12B$1.05B$801.8M$726.4M$597.5M$548.5M$493M$454.9M$435.8M$439.7M$490.4M$509.8M$543.5M$553.7M$432.2M$398.3M$368.1M$299.5M$247.5M$229.3M
Deferred Income Tax-$1.71B-$2.68B-$2.34B-$2.19B-$802.3M-$134.5M$62.4M$326.8M-$787.9M$439.5M-$748.4M$36.8M$265.9M$126M-$268.5M$559.7M$189.9M$442.6M$122.9M$346.8M-$347.5M$772.4M$130.9M$346.5M$273.8M-$442.7M$27.1M$25.4M-$293M$207.3M$144M$172.2M-$231.6M-$184.3M$0$0$0
Stock-Based Compensation$626M$645.6M$628.5M$371.1M$342.8M$308.1M$312.4M$279.5M$281.3M$255.3M$217.8M$156M$144.9M$141.5M$147.4M$231M$368.5M$255.3M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable-$7B-$2.16B-$2.45B-$299.6M-$1.28B-$1.35B-$127.2M-$10.76B-$357M-$5.09B-$4.99B$117.4M-$152.7M$361.8M-$188.8M-$319.1M$0$799.1M$0$243.9M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Inventory-$4.67B-$2.51B-$1.43B-$599.7M-$235.9M-$533.4M-$258.7M$7.8M-$253.9M-$328.2M-$736.3M-$307.1M-$286.5M-$307.9M$203.1M$157M-$179M$84.8M$154.3M-$60.2M$72.1M-$111.6M-$170.8M-$285.1M-$184.2M$9.8M$16.9M-$55.6M-$65.8M-$42.2M-$22.1M$107.1M-$192.3M-$198.4M-$116.1M-$59.1M-$21.9M
  Accounts Payable$10.19B$2.61B$4.27B$1.33B-$1.01B$1.27B-$477.7M-$284.5M$916.3M$819M$461.6M$0-$70.3M-$336.1M$591.4M-$363.9M$0-$184.7M$927.2M-$936M-$1.46B$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Other Working Capital-$6.61B-$3.33B-$3.45B-$433.2M$1.52B-$135.1M-$823.6M$8.66B$2.9B$4.11B$4.12B$673.2M$116.5M$231M$642.7M$340.5M-$777.9M$1.65B-$1.2B-$43M-$555.8M-$1.13B$254.6M-$1.26B$106.8M$767.9M-$442.7M$164.7M$546.2M-$142.9M-$210.6M-$528.4M$63.2M$121M-$221.1M$215.3M-$136.1M
Total Working Capital Change-$8.09B-$5.38B-$3.06B-$800K-$1.01B-$747.4M-$1.69B-$2.38B$3.2B-$484.1M-$1.14B$483.5M-$393M-$51.2M$1.25B-$185.5M-$956.9M$2.35B-$117M-$795.3M-$1.95B-$1.24B$83.8M-$1.54B-$77.4M$777.7M-$425.8M$109.1M$480.4M-$185.1M-$232.7M-$421.3M-$129.1M-$77.4M-$337.2M$156.2M-$158M
Other Non-Cash Items$3.35B$3.88B$2.24B$1.63B$1.71B-$444.2M-$3.4B$2.46B$1.55B$406.1M$798.3M$12.6M-$413.2M-$462.3M$385.9M-$146.1M-$892.6M$5.2B$1.15B$959.9M$1.5B$927.5M$322.7M$65.4M$230.3M-$97.1M-$142.3M-$100.2M$2.09B-$97.8M-$931.3M$63.1M$988.2M$549.5M-$22.4M-$56.6M$21.8M
Net Cash from Operating$16.81B$8.82B$4.24B$7.59B$7.37B$6.5B$4.84B$5.52B$5.62B$4.85B$2.96B$4.46B$5.74B$5.3B$7.23B$6.86B$4.34B$7.3B$5.15B$3.98B$1.91B$2.87B$3.65B$2.07B$3.66B$3.73B$2.62B$2.63B$2.4B$1.99B$1.82B$1.53B$1.52B$1.48B$1.25B$1.47B$1.03B
Investing Activities
Capital Expenditures-$7.84B-$8.4B-$3.45B-$1.85B-$1.31B-$2.03B-$1.35B-$1.21B-$2.16B-$1.09B-$1.63B-$1.57B-$1.01B-$1.04B-$1.69B-$1.19B-$855M-$947.2M-$1.08B-$1.08B-$1.3B-$1.9B-$1.71B-$1.13B-$884M-$677.9M-$528.3M-$419.9M-$366.3M-$443.9M-$551.3M-$576.5M-$633.5M-$1B-$1.14B-$1.01B-$554.5M
Acquisitions-$661M-$947.7M-$1.04B-$327.2M-$747.4M-$849.3M-$6.94B$0-$882.1M-$45M-$5.28B-$551.4M-$43.7M-$199.3M-$282.5M-$609.4M-$72.3M-$6.08B-$2.67B$65.2M$11.1M-$71.7M$61.2M$36.8M$31.6M$0$1.68B$0$1.23B-$97.1M-$36.8M-$4.05B$5.4M$10.6M$0$21.1M$17.4M
Purchases of Investments-$645M-$775.8M-$829M-$707.6M-$1.01B-$370.1M-$290.2M-$950.1M-$8B-$5.67B-$4.07B-$11.44B-$15.57B-$7.62B-$4.71B-$1.75B-$432.3M-$2.41B-$1.13B-$1.31B-$1.18B-$13.09B-$7.01B-$5.84B-$3.06B$0-$162.8M-$57.6M-$388.5M-$294.3M-$372.9M-$1.15B-$1B-$740.2M-$942.6M-$504.4M-$605.2M
Sales of Investments$964M$522.5M$700.3M$463.6M$847.4M$886.8M$746.4M$6.06B$7.44B$3.73B$5.23B$15.06B$14.56B$4.73B$2.14B$584.7M$1.51B$2.55B$800.1M$2.76B$607.8M$14.85B$7.54B$4.78B$319M$983.9M$216.1M$273.1M$365.7M$396.9M$430.8M$1.39B$889.3M$764.2M$1.3B$501.5M$352M
Other Investing Activities-$2.79B$303.1M-$2.53B-$1.34B-$644.3M$102.8M-$248.7M-$2B-$175.1M-$56.7M$5.77B-$5.41B$800K$1.3B-$277.2M-$194.7M-$4.5M-$381.1M-$245M$179M-$353.6M-$477.6M-$217.2M-$316.1M-$369.7M-$1.36B-$116.6M-$89.5M-$34.2M-$29.6M-$32.6M-$14.2M-$126.2M$39.3M-$72.4M-$66.8M-$34.5M
Net Cash from Investing-$10.97B-$9.3B-$7.15B-$3.76B-$2.87B-$2.26B-$8.08B$1.91B-$3.78B-$3.14B$26.8M-$3.91B-$2.07B-$2.83B-$4.82B-$3.16B$142.8M-$7.27B-$4.33B$608.4M-$2.22B-$684.8M-$1.33B-$2.47B-$3.96B-$1.06B$1.09B-$293.9M$809.7M-$468M-$562.8M-$4.41B-$866.7M-$928.2M-$855.7M-$1.06B-$824.8M
Financing Activities
Debt Repaid-$12.39B-$10.75B-$3.96B$1.56B-$505.4M-$1.79B-$3.69B-$1.47B-$1.6B-$1.21B-$2.5B$41.9M$10.5M$1.51B$61.7M-$100K-$2.4B$649.7M-$1.45B$2.78B-$2B-$160.8M-$42.7M-$1.23B-$594.7M$229.1M-$690.6M$176.4M$1.15B$811.8M-$34.8M-$3.43B-$191.3M-$97.6M$621.3M-$1.1B$6.7M
Common Stock Issuance$0$0$0$0$0$0$0$1.66B$0$0$0$0$0$0$0$0$0$0$24.7M$59.6M$105.9M$104.5M$103.1M$64.6M$109.5M$178.4M$310.2M$414M$365.4M$218.4M$54.7M$50.5M$19.8M$26M$39.3M$21.3M$28.6M
Common Stock Repurchases-$4.11B-$2.5B-$750M-$1.5B-$1.25B-$500M-$4.4B-$4.15B-$299.8M-$600.1M-$749.5M-$800M-$1.7B-$721.1M$0$0$0$0$0-$122.1M-$377.9M$0-$281.1M-$385.2M-$545.7M-$1.05B-$1.45B-$2.17B-$351.3M-$314.5M-$156M-$111M-$25.8M-$68.5M-$69.2M-$1.07B-$186.9M
Dividends Paid-$5.38B-$4.68B-$4.07B-$3.54B-$3.09B-$2.69B-$2.41B-$2.31B-$2.19B-$2.16B-$2.13B-$2.1B-$2.12B-$2.19B-$2.18B-$2.17B-$2.15B-$2.06B-$1.85B-$1.74B-$1.65B-$1.54B-$1.44B-$1.34B-$1.21B-$1.13B-$1B-$877.7M-$818M-$753.2M-$747.2M-$723.1M-$708.4M-$643.7M-$582.7M-$450.1M-$372M
Other Financing Activities-$772M-$490.6M-$335M-$308.9M-$295.9M-$241.6M-$200.1M-$372.8M-$364.4M-$300.8M$139.2M$96.1M$0$0$6M$19.4M$42.6M-$8.1M-$600K$9.9M$39.8M$0$0$0$0$0$0$0$0$0$0$192.5M$0$0$955.7M$0$0
Net Cash from Financing-$2.21B$1.23B$3.5B-$5.41B-$4.13B-$3.14B-$2.32B-$5.9B$142.6M-$559.8M-$2.92B-$166.4M-$3.83B-$4.42B-$2.37B-$2.02B-$5.53B$2.35B-$844.9M-$4.58B-$1.88B$203.7M-$1.58B-$422M-$1.05B-$2.23B-$1.45B-$2.81B-$1.95B-$1.66B-$813.7M$2.84B-$523.1M-$588.6M-$278.2M-$393.7M-$537M
Forex Effect$372M-$296.7M$168.6M-$167.6M-$205.7M$216M-$89.9M-$63.6M-$20.5M-$236.4M-$85.6M-$341.5M-$21.5M$43.9M-$110.9M-$144.8M$21.6M-$96.6M$129.7M$97.1M-$175.8M$220.6M$73.5M$69.3M-$60.7M-$31M-$49M$25M-$121.7M-$48.1M$14.5M$32.7M-$19.9M-$13.5M$8.3M$2.4M-$9M
Net Change in Cash$4B$449.8M$751.6M-$1.75B$161.4M$1.32B-$5.66B$1.46B$1.95B$915.7M-$205.2M$41.4M-$188.6M-$1.9B-$70.7M$1.53B-$1.03B$2.28B$111.2M$102.6M-$2.36B$2.61B$810.4M-$756.4M-$1.41B$414.5M$2.2B-$451.8M$1.13B-$185.8M$462.6M-$2.7M$107.2M-$46.8M$129M$27.2M-$338.2M
Supplementary Data
Operating Cash Flow$16.81B$8.82B$4.24B$7.59B$7.37B$6.5B$4.84B$5.52B$5.62B$4.85B$2.96B$4.46B$5.74B$5.3B$7.23B$6.86B$4.34B$7.3B$5.15B$3.98B$1.91B$2.87B$3.65B$2.07B$3.66B$3.73B$2.62B$2.63B$2.4B$1.99B$1.82B$1.53B$1.52B$1.48B$1.25B$1.47B$1.03B
Capital Expenditure-$7.84B-$5.06B-$7.39B-$2.99B-$1.98B-$2.03B-$1.35B-$3.02B-$2.16B-$1.09B-$1.63B-$1.57B-$1.09B-$1.04B-$1.69B-$1.19B-$855M-$947.2M-$1.08B-$1.08B-$1.3B-$1.9B-$1.71B-$1.13B-$884M-$677.9M-$528.3M-$419.9M-$366.3M-$443.9M-$551.3M-$576.5M-$633.5M-$1B-$1.14B-$1.01B-$554.5M
Free Cash Flow$8.97B$3.76B-$3.15B$4.6B$5.39B$4.47B$3.48B$2.51B$3.45B$3.76B$1.34B$2.89B$4.64B$4.26B$5.54B$5.67B$3.48B$6.35B$4.07B$2.9B$615.5M$971.4M$1.94B$939.8M$2.78B$3.05B$2.09B$2.21B$2.03B$1.55B$1.27B$955.8M$883.4M$481.4M$112.2M$467.1M$478.1M
Cash at Beginning$3.27B$2.82B$2.07B$3.82B$3.66B$2.34B$8B$6.54B$4.58B$3.67B$3.87B$3.83B$4.02B$5.92B$5.99B$4.46B$5.5B$3.22B$3.11B$3.01B$5.37B$2.76B$1.95B$2.7B$4.11B$3.7B$1.5B$1.95B$813.7M$999.5M$536.9M$539.6M$432.4M$479.2M$350.2M$323M$661.2M
Cash at End$7.27B$3.27B$2.82B$2.07B$3.82B$3.66B$2.34B$8B$6.54B$4.58B$3.67B$3.87B$3.83B$4.02B$5.92B$5.99B$4.46B$5.5B$3.22B$3.11B$3.01B$5.37B$2.76B$1.95B$2.7B$4.11B$3.7B$1.5B$1.95B$813.7M$999.5M$536.9M$539.6M$432.4M$479.2M$350.2M$323M